Your browser doesn't support javascript.
loading
Bloqueadores beta en shock séptico: una revisión / Beta-blockers in septic shock: a review
Vela-Vásquez, RS; Grigorov-Tzenkov, I; Aguilar, JL.
Affiliation
  • Vela-Vásquez, RS; Hospital Son LLatzer. Palma de Mallorca. España
  • Grigorov-Tzenkov, I; Hospital Son LLatzer. Palma de Mallorca. España
  • Aguilar, JL; Hospital Son LLatzer. Palma de Mallorca. España
Rev. esp. anestesiol. reanim ; 62(2): 90-95, feb. 2015. ilus
Article in Spanish | IBECS | ID: ibc-132926
Responsible library: ES1.1
Localization: BNCS
RESUMEN
La excesiva estimulación simpática está asociada con efectos adversos a nivel cardiovascular y sistémico, que pueden afectar negativamente los resultados en el shock séptico. El bloqueo de los receptores beta adrenérgicos ha mostrado controlar eficazmente el incremento desproporcionado de la frecuencia cardiaca, conservando un perfil hemodinámico favorable y al parecer mejorando la eficiencia del sistema cardiovascular para mantener la perfusión tisular. Adicionalmente, ha mostrado modular favorablemente la inmunosupresión inducida por catecolaminas, así como disminuir la resistencia a la insulina, el catabolismo proteico y la expresión de citocinas proinflamatorias asociadas a disfunción cardiovascular. El bloqueo selectivo de los receptores beta-1 parece ofrecer mejores resultados que el bloqueo no selectivo, sugiriendo incluso un impacto positivo en la mortalidad. Son necesarios futuros ensayos clínicos para confirmar estos hallazgos y definir los alcances de estos beneficios (AU)
ABSTRACT
In septic shock, high adrenergic stress is associated with cardiovascular and systemic adverse effects, which can negatively affect the results. Beta-adrenergic receptor block has been shown to be effective in controlling the disproportionate increase in heart rate, maintaining a favorable hemodynamic profile and apparently improving the efficiency of the cardiovascular system in order to maintain tissue perfusion. They have also been shown to modulate favorably catecholamine-induced immunosuppression and to decrease insulin resistance, protein catabolism, and proinflammatory cytokine expression associated with cardiovascular dysfunction. Selective beta-1 blockers appear to provide better results than non-selective blockers, even suggesting a positive impact on mortality. Future clinical trials are still needed to confirm these findings and define the scope of their benefits (AU)
Subject(s)
Search on Google
Collection: National databases / Spain Health context: SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Sepsis Database: IBECS Main subject: Shock, Septic / Receptors, Adrenergic, beta / Sepsis Limits: Female / Humans / Male Language: Spanish Journal: Rev. esp. anestesiol. reanim Year: 2015 Document type: Article Institution/Affiliation country: Hospital Son LLatzer/España
Search on Google
Collection: National databases / Spain Health context: SDG3 - Target 3.3 End transmission of communicable diseases Health problem: Sepsis Database: IBECS Main subject: Shock, Septic / Receptors, Adrenergic, beta / Sepsis Limits: Female / Humans / Male Language: Spanish Journal: Rev. esp. anestesiol. reanim Year: 2015 Document type: Article Institution/Affiliation country: Hospital Son LLatzer/España
...